You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME / ABIM MOC / CE

Influenza: Antiviral Treatments and Prophylaxis in Children and Adolescents

  • Authors: Leigh Montejo, DNP, FNP-BC; Tina Q. Tan, MD
  • CME / ABIM MOC / CE Released: 11/14/2022
  • Valid for credit through: 11/14/2023
Start Activity

  • Credits Available

    Physicians - maximum of 0.50 AMA PRA Category 1 Credit(s)™

    ABIM Diplomates - maximum of 0.50 ABIM MOC points

    Nurses - 0.50 ANCC Contact Hour(s) (0.25 contact hours are in the area of pharmacology)

    Pharmacists - 0.50 Knowledge-based ACPE (0.050 CEUs)

    IPCE - 0.50 Interprofessional Continuing Education (IPCE) credit

    You Are Eligible For

    • Letter of Completion
    • ABIM MOC points

Target Audience and Goal Statement

This activity is intended for pediatricians, primary care physicians, nurse practitioners, nurses, and other clinicians who treat pediatric patients with influenza.

The goal of this activity is for learners to be better able to improve their ability to recommend current treatments and prophylaxis for influenza in children and adolescents.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Influenza antiviral medications for prophylaxis or treatment of children and adolescents
  • Have greater competence related to
    • Selecting appropriate influenza antiviral prophylaxis or treatments in children and adolescents
  • Demonstrate greater confidence in their ability to
    • Manage influenza in children and adolescents in an interprofessional team environment
    • Treat children and adolescents for influenza and prevent its spread to household contacts


Disclosures

Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.


Faculty

  • Leigh Montejo, DNP, FNP-BC

    Assistant Professor
    Johns Hopkins - School of Nursing
    Baltimore, MD
    Family Nurse Practitioner
    Premise Health
    Tampa, Florida

    Disclosures

    Participation by Dr Montejo does not constitute or imply endorsement by the Johns Hopkins University or the Johns Hopkins Hospital and Health System.

    Leigh Montejo, DNP, FNP-BC, has no relevant financial relationships.

  • Tina Q. Tan, MD

    Professor, Pediatrics and Infectious Diseases
    Northwestern University Feinberg School of Medicine
    Pediatric Infectious Diseases Attending
    Ann and Robert H. Lurie Children's Hospital of Chicago
    Chicago, Illinois

    Disclosures

    Tina Q. Tan, MD, has the following relevant financial relationships:
    Consultant or advisor for: GlaxoSmithKline; Merck; Moderna; Pfizer; Sanofi Pasteur
    Research funding from: GlaxoSmithKline; Pfizer

Editors

  • Iwona Misiuta, PhD, MHA

    Medical Education Director, Medscape, LLC

    Disclosures

    Iwona Misiuta, PhD, MHA, has no relevant financial relationships.

  • Kalanethee Paul-Pletzer, PhD

    Medical Education Director, Medscape, LLC

    Disclosures

    Kalanethee Paul-Pletzer, PhD, has no relevant financial relationships.

Compliance Reviewer/Nurse Planner

  • Leigh Schmidt, MSN, RN, CNE, CHCP

    Associate Director, Accreditation and Compliance, Medscape, LLC

    Disclosures

    Leigh Schmidt, MSN, RN, CNE, CHCP, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.


Accreditation Statements



In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

This activity was planned by and for the healthcare team, and learners will receive 0.50 Interprofessional Continuing Education (IPCE) credit for learning and change.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.50 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

    Contact This Provider

    For Nurses

  • Awarded 0.50 contact hour(s) of nursing continuing professional development for RNs and APNs; 0.25 contact hours are in the area of pharmacology.

    Contact This Provider

    For Pharmacists

  • Medscape designates this continuing education activity for 0.50 contact hour(s) (0.050 CEUs) (Universal Activity Number: UAN JA0007105-0000-22-245-H01-P).

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME / ABIM MOC / CE

Influenza: Antiviral Treatments and Prophylaxis in Children and Adolescents

Authors: Leigh Montejo, DNP, FNP-BC; Tina Q. Tan, MDFaculty and Disclosures

CME / ABIM MOC / CE Released: 11/14/2022

Valid for credit through: 11/14/2023

processing....

Educational Impact Challenge

The goal of this activity is for learners to be better able to improve their ability to recommend current treatments and prophylaxis for influenza in children and adolescents.

Before you begin this activity, please assess your clinical knowledge by completing this brief survey. Answering these questions again after the activity will allow you to see what you learned and to compare your answers with those of your peers.